Mostrando ítems 1-20 de 49
Marull Arnall, Anna (Fecha de defensa: 2021-06-21)
Currently, automatic analyzers based on highly accurate methods can determine hematologic parameters in a fast and reliable way which is important to detect abnormalities in blood cells. In laboratories with a high care ...
Sanjuan Menéndez, Estel·la (Fecha de defensa: 2014-12-12)
Objetivo:Determinar si los criterios clásicos de activación del Código Ictus (CCACI) permiten seleccionar de manera adecuada aquellos pacientes candidatos a recibir tratamientos de reperfusión (TDR). Pacientes y ...
Llobera Serentill, Àlex (Fecha de defensa: 2018-03-09)
Cardiovascular risk factors control is low in peripheral artery disease patients. Leukocyte count over7.8 K/mcL or neutrophil count over 4.6 K/mcL are predictors of increased risk for heart coronary disease, cerebral ...
Quesada Sabaté, Miquel (Fecha de defensa: 2017-02-17)
Background There is few epidemiological data of peripheral arterial disease (PAD) in our environment. The recommendation of screening with ankle brachial index (ABI) in asymptomatic individuals is controversial. Evidence ...
Vilanova Vilà, Marta (Fecha de defensa: 2015-04-17)
Introducció La promoció de la salut cardiovascular comporta capacitar les persones per adquirir hàbits saludables. Objectiu Avaluar millora dels hàbits de salut cardiovascular amb intervenció comunitària de persones de ...
Olivet Pujol, Josep (Fecha de defensa: 2015-10-28)
A Catalunya, cada any perden la vida més de 3.000 persones degut a la mort sobtada cardíaca. Per aconseguir una major supervivència són fonamentals una sèrie d'accions que constitueixen la «cadena de supervivència» i la ...
Parramon Font, Dídac (Fecha de defensa: 2019-07-26)
Cardiovascular diseases are the leading cause of mortality and morbidity worldwide as well as in our population. One of the main cardiovascular prevention strategies is to identify healthy patients who are at risk of ...
Suñer Soler, Rosa (Fecha de defensa: 2010-06-28)
S'han estudiat 1003 pacients amb el diagnòstic de Malaltia Vascular Cerebral (MVC) aguda ingressats a la unitat de neurologia de l'Hospital Josep Trueta de Girona en el període de gener de 2005 a juliol de 2007. S'ha ...
Aboal Viñas, Jaime (Fecha de defensa: 2020-06-26)
Introduction: Achieving optimal times of reperfusion in STEMI patients transferred for primary percutaneos coronary intervention (PCI) remains a challenge, particularly in geographically disperse regions. Our goal was to ...
Matés Ramírez, Jesús (Fecha de defensa: 2018-01-19)
Arrhythmogenic cardiac diseases are the main cause of SCD among the population under 35 years of age. Despite the improvements in genetic diagnosis, the percentage of cases that remain unexplained after genetic analysis ...
Bosch Calero, Cristina (Fecha de defensa: 2016-03-08)
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a sudden cardiac death (SCD) associated disease characterized by the presence of polymorphic or bidirectional ventricular tachycardia during emotional or ...
Puig Alcántara, Josep (Fecha de defensa: 2014-12-03)
Introducción: El infarto cerebral és una de las primeras causas de morbi-mortalidad en nuestra sociedad. La fibrinolisis intravenosa con activador tisular del plasminógeno es el tratamiento de elección en las primeras 4.5 ...
Serrat Costa, Mar (Fecha de defensa: 2019-05-24)
Introduction: Arterial hypertension (AHT) is the main risk factor in attributable mortality. It is therefore considered one of the most significant public health problems, in particular for primary health care, which is ...
Comajoan von Arend, Pau (Fecha de defensa: 2019-12-18)
Recombinant tissue plasminogen activator (rt-PA) is currently the only FDA-approved drug for the treatment of acute ischaemic stroke. However, the application of this therapy is limited to <5-7% of patients due to the ...
Reverté i Villarroya, Sílvia (Fecha de defensa: 2017-04-27)
We conducted a prospective, longitudinal and comparative sample of patients with acute ischaemic stroke who were previously randomized for a clinical trial (REVASCAT) with two groups (intervention and control) according ...
Martinez Moreno, Rebecca (Fecha de defensa: 2021-06-02)
Ion channel mutations can cause defects on the electrical cellular activity, leading to arrhythmogenic diseases also known as channelopathies. Genetic analysis has been a useful tool to identify these mutations as the cause ...
Paz Bermejo, Marco Antonio (Fecha de defensa: 2022-05-30)
Background. The relative efficacy of antihypertensive drugs/combinations is not well known; Identifying the most effective ones, and the patients’ characteristics associated to best performance of the drugs will improve ...
Vázquez Oliva, Gabriel (Fecha de defensa: 2019-02-08)
Acute myocardial infarction incidence rates are very high in those over 74, with a tendency to decrease in recent years in men and are always higher in men than in women. Mortality rates over the age of 74 are very high. ...
Chevarría Montesinos, Julio Leonel (Fecha de defensa: 2019-04-25)
The sodium in 24H urine is the standard to quantify the intake. The objective is to develop a method to stimate using isolated urine sample, analyze the reliability, concordance and clinical utility. Observational, ...
Vila Belmonte, Àlex (Fecha de defensa: 2019-12-13)
Familial hypercholesterolemia (FH) is the most frequent hereditary cause of premature coronary heart disease. The aim of this doctoral thesis is to determine the prevalence of subjects with FH phenotype (FH-P); to describe ...